Literature DB >> 20709729

Linoleic acid supplement in cystic fibrosis: friend or foe?

Neeraj Vij.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20709729      PMCID: PMC2980394          DOI: 10.1152/ajplung.00257.2010

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


× No keyword cloud information.
  19 in total

Review 1.  Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.

Authors:  Thomas S Murray; Marie Egan; Barbara I Kazmierczak
Journal:  Curr Opin Pediatr       Date:  2007-02       Impact factor: 2.856

2.  Prostanoid biosynthesis in patients with cystic fibrosis.

Authors:  B Strandvik; E Svensson; H W Seyberth
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1996-12       Impact factor: 4.006

Review 3.  Role of polyunsaturated fatty acids in lung disease.

Authors:  J Schwartz
Journal:  Am J Clin Nutr       Date:  2000-01       Impact factor: 7.045

4.  Early pulmonary inflammation in infants with cystic fibrosis.

Authors:  T Z Khan; J S Wagener; T Bost; J Martinez; F J Accurso; D W Riches
Journal:  Am J Respir Crit Care Med       Date:  1995-04       Impact factor: 21.405

5.  Serum fatty acid profiles in cystic fibrosis patients and their parents.

Authors:  A B Christophe; W J Warwick; R T Holman
Journal:  Lipids       Date:  1994-08       Impact factor: 1.880

6.  CHOP transcription factor mediates IL-8 signaling in cystic fibrosis bronchial epithelial cells.

Authors:  Neeraj Vij; Martha O Amoako; Steven Mazur; Pamela L Zeitlin
Journal:  Am J Respir Cell Mol Biol       Date:  2007-08-20       Impact factor: 6.914

7.  Increased mole fraction of arachidonic acid in bronchial phospholipids in patients with cystic fibrosis.

Authors:  H Gilljam; B Strandvik; A Ellin; L G Wiman
Journal:  Scand J Clin Lab Invest       Date:  1986-10       Impact factor: 1.713

8.  Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts.

Authors:  H Grassmé; V Jendrossek; A Riehle; G von Kürthy; J Berger; H Schwarz; M Weller; R Kolesnick; E Gulbins
Journal:  Nat Med       Date:  2003-02-03       Impact factor: 53.440

9.  Plasma lipid concentrations in children with cystic fibrosis: the value of a high-fat diet and pancreatic supplementation.

Authors:  G C Burdge; A J Goodale; C M Hill; P J Halford; E J Lambert; A D Postle; C J Rolles
Journal:  Br J Nutr       Date:  1994-06       Impact factor: 3.718

10.  Effect of linoleic acid intake on growth of infants with cystic fibrosis.

Authors:  A W van Egmond; M R Kosorok; R Koscik; A Laxova; P M Farrell
Journal:  Am J Clin Nutr       Date:  1996-05       Impact factor: 7.045

View more
  2 in total

1.  Linoleic acid metabolite leads to steroid resistant asthma features partially through NF-κB.

Authors:  Lipsa Panda; Atish Gheware; Rakhshinda Rehman; Manish K Yadav; B S Jayaraj; SubbaRao V Madhunapantula; Padukudru Anand Mahesh; Balaram Ghosh; Anurag Agrawal; Ulaganathan Mabalirajan
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

Review 2.  Is the ENaC Dysregulation in CF an Effect of Protein-Lipid Interaction in the Membranes?

Authors:  Birgitta Strandvik
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.